Trial intelligence / Profile preview

Efficacy and Safety of Ulipristal Acetate (CDB-2914) for Emergency Contraception

NCT00411684Phase 3Completed

Sponsor
HRA Pharma
Start
Nov 2006
Primary completion
Apr 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ulipristal in pregnancy, sponsored by HRA Pharma. Started Nov 2006; status: completed.

02

Drugs

ulipristal
03

Conditions

pregnancy

Beyond the preview

Go deeper on NCT00411684.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00411684.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call